These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4157774)

  • 1. Blood-serotonin deficiency in Down's syndrome.
    Tu JB; Zellweger H
    Lancet; 1965 Oct; 2(7415):715-6. PubMed ID: 4157774
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum total tryptophan and free tryptophan concentration in Down's syndrome its relation to serum serotonin concentration.
    Hoshino Y; Kaneko M; Yashima Y; Kumashiro H
    Fukushima J Med Sci; 1980 Jun; 27(1-2):39-51. PubMed ID: 6460675
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolism of vitamin B6 in Down's syndrome.
    McCoy EE; Colombini C; Ebadi M
    Ann N Y Acad Sci; 1969 Sep; 166(1):116-25. PubMed ID: 4243377
    [No Abstract]   [Full Text] [Related]  

  • 4. Defective binding of 5-HT by blood platelets from children with the trisomy 21 form of Down's syndrome.
    Boullin DJ; Coleman M; O'Brien RA
    J Physiol; 1969 Oct; 204(2):128P+. PubMed ID: 4241928
    [No Abstract]   [Full Text] [Related]  

  • 5. [Letter: "Basis therapy" and especially "cell therapy" in Down's syndrome].
    Betke K; Schäfer KH
    Monatsschr Kinderheilkd (1902); 1975 Sep; 123(9):667-71. PubMed ID: 126368
    [No Abstract]   [Full Text] [Related]  

  • 6. Catabolism of serotonin in Down's syndrome (tisomy 21).
    Kamoun P; Lafourcade G; Jerome H
    Biomedicine; 1974 Oct; 21(10):426-8. PubMed ID: 4281668
    [No Abstract]   [Full Text] [Related]  

  • 7. Down's syndrome. Central monoamine turnover in patients with diminished platelet serotonin.
    Lott IT; Murphy DL; Chase TN
    Neurology; 1972 Sep; 22(9):967-72. PubMed ID: 4263686
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer-like brain monoamine deficits in adults with Down's syndrome.
    Reynolds GP; Godridge H
    Lancet; 1985 Dec; 2(8468):1368-9. PubMed ID: 2866421
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J; Partington MW
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract]   [Full Text] [Related]  

  • 10. Fate of 14C-labelled tryptophan and 5-hydroxytryptophan in Down's syndrome.
    Airaksinen EM; Airaksinen MM; Pentikäinen P
    Ann Clin Res; 1973 Dec; 5(6):385-91. PubMed ID: 4275982
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Tryptophan and serotonin in Down syndrome.
    Lancet; 1974 Dec; 2(7896):1554. PubMed ID: 4140989
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet-rich plasma 5-hydroxytryptamine, urinary 5-hydroxyindoleacetic acid and tryptophan ingestion in mongols.
    Airaksinen EM
    J Ment Defic Res; 1971 Dec; 15 Pt 4(0):244-56. PubMed ID: 4279295
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the L-tryptophan metabolism in children with Down's syndrome].
    Vassella F; Colombo JP; Gloor RD; Rossi E
    Helv Paediatr Acta; 1968 Aug; 23(4):419-28. PubMed ID: 4234242
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormalities of 5-hydroxytryptamine uptake and binding by blood platelets from children with Down's syndrome.
    Boullin DJ; O'Brien RA
    J Physiol; 1971 Jan; 212(2):287-97. PubMed ID: 4251289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer-like neurotransmitter deficits in adult Down's syndrome brain tissue.
    Godridge H; Reynolds GP; Czudek C; Calcutt NA; Benton M
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):775-8. PubMed ID: 2440994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood phospholipids in patients with Down's disease].
    Aitbaev KA
    Sov Zdravookhr Kirg; 1973; 6():18-20. PubMed ID: 4273356
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of pyridoxal-5-phosphate in human blood between the cells and the plasma: effect of oral administration of pyridoxine on the ratio in Down's and hyperactive patients.
    Bhagavan HN; Coleman M; Coursin DB
    Biochem Med; 1975 Oct; 14(2):201-8. PubMed ID: 130903
    [No Abstract]   [Full Text] [Related]  

  • 18. Down's syndrome: transport, storage, and metabolism of serotonin in blood platelets.
    Lott IT; Chase TN; Murphy DL
    Pediatr Res; 1972 Sep; 6(9):730-5. PubMed ID: 4264688
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.
    Rumble B; Retallack R; Hilbich C; Simms G; Multhaup G; Martins R; Hockey A; Montgomery P; Beyreuther K; Masters CL
    N Engl J Med; 1989 Jun; 320(22):1446-52. PubMed ID: 2566117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.
    Schapiro MB; Haxby JV; Grady CL; Duara R; Schlageter NL; White B; Moore A; Sundaram M; Larson SM; Rapoport SI
    J Neurol Neurosurg Psychiatry; 1987 Jun; 50(6):766-74. PubMed ID: 2956363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.